Genetic alterations in a primary medullary thyroid carcinoma and its lymph node metastasis in a patient with 15 years follow-up

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  González Yebra, Beatriz ^a,b   Peralta, Raúl ^a,c   González, Ana L ^a   Ayala Garcia, Marco A ^b   de Zarate, María E Medrano Ortiz ^c   Salcedo, Mauricio ^c  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b Pediatrics Pediatrics Endocrinology   (Mexico)

^c HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

Chromosomal alterations; M918T RET mutation; Sporadic MTC

Indexed keywords

PROTEIN RET; RET PROTEIN, HUMAN;

AGED; ARTICLE; CASE REPORT; CHROMOSOME 16; CHROMOSOME 18; CHROMOSOME 6; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FOLLOW UP; GENETICS; HUMAN; LYMPH NODE METASTASIS; PATHOLOGY; THYROID TUMOR;

AGED; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, PAIR 6; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS;

EID: 84861856487     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-63     Document Type: Article

References (22)

1. Randolph GW, Maniar D. Medullary carcinoma of the thyroid. Cancer Control 2000, 7:253-261.
2. Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M, Busnardo B. Medullary thyroid carcinoma: clinical features and long-term follow-up of seventy-eight patients treated between 1969 and 1986. Thyroid 1998, 8:517-523. 10.1089/thy.1998.8.517, 9669290.
3. Ito Y, Miyauchi A, Yabuta T, Fukushima M, Inoue H, Tomoda C, Uruno T, Kihara M, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution. World J Surg 2009, 33(1):58-66. 10.1007/s00268-008-9795-2, 19005720.
4. González B, Salcedo M, Medrano ME, Mantilla A, Quiñonez G, Benítez-Bibriesca L, Rodríguez-Cuevas S, Cabrera L, de León B, Altamirano N, Tapia J, Dawson B. RET oncogene mutations in medullary thyroid carcinoma in Mexican families. Arch Med Res 2003, 34(1):41-49. 10.1016/S0188-4409(02)00461-7, 12604374.
5. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Höppener JW, van Amstel HK, Romeo G. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994, 367:375-376. 10.1038/367375a0, 7906866.
6. Eng C, Smith DP, Mulligan LM, Nagai MA, Healey CS, Ponder MA, Gardner E, Scheumann GF, Jackson CE, Tunnacliffe A. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumors. Hum Mol Genet 1994, 3:237-241. 10.1093/hmg/3.2.237, 7911697.
7. Zedenius J, Wallin G, Hamberger B, Nordenskjöld M, Weber G, Larsson C. Somatic and MEN2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Hum Mol Genet 1994, 3:1259-1262. 10.1093/hmg/3.8.1259, 7987299.
8. Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Pfragner R, Behmel A, Lorenzo MJ. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer 1995, 12:209-212. 10.1002/gcc.2870120308, 7536460.
9. Scurinni C, Quadro L, Fattoruso O, Verga U, Libroia A, Lupoli G, Cascone E, Marzano L, Paracchi S, Busnardo B, Girelli ME, Bellastella A, Colantuoni V. Germline and somatic mutations of the RET proto-oncogene in apparently sporadic medullary thyroid carcinomas. Mol Cell Endocrinol 1998, 137:51-57. 10.1016/S0303-7207(97)00234-7, 9607728.
10. Zedenius J, Larsson C, Bergholm U, Bovée J, Svensson A, Hallengren B, Grimelius L, Bäckdahl M, Weber G, Wallin G. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas. J Clin Endocrinol Metabol 1995, 80:3088-3090.
11. Schilling T, Bürk J, Sinn HP, Clemens A, Otto HF, Höppner W, Herfarth C, Ziegler R, Schwab M, Raue F. Prognostic value of codon 918 (ATG → ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer 2001, 95:62-66. 10.1002/1097-0215(20010120)95:1<62::AID-IJC1011>3.0.CO;2-1, 11241313.
12. Romei C, Elisei R, Pinchera A, Ceccherini I, Molinaro E, Mancusi F, Martino E, Romeo G, Pacini F. Somatic mutations of the RET protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metabol 1996, 81:1619-1622.
13. Elisei R, Cosci B, Romei C, Bottici V, Renzini G, Molinaro E, Agate L, Vivaldi A, Faviana P, Basolo F, Miccoli P, Berti P, Pacini F, Pinchera A. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metabol 2008, 93:682-687.
14. Pinkel D, Albertson DG. Comparative genomic hybridization. Annu Rev Genomics Hum Genet 2005, 6:331-354. 10.1146/annurev.genom.6.080604.162140, 16124865.
15. Weiss MM, Hermsen MA, Meijer GA, van Grieken NC, Baak JP, Kuipers EJ, van Diest PJ. Comparative genomic hybridization. Mol Pathol 1999, 52:243-251. 10.1136/mp.52.5.243, 395705, 10748872.
16. Frisk T, Zedenius J, Lundberg J, Wallin G, Kytölä S, Larsson C. CGH alterations in medullary thyroid carcinomas in relation to the RET M918T mutation and clinical outcome. Int J Oncol 2001, 18:1219-1225.
17. Ye L, Santarpia L, Cote GJ, El-Naggar AK, Gagel RF. High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma. J Clin Endocrinol Metab 2008, 93:4367-4372. 10.1210/jc.2008-0912, 2729231, 18765511.
18. Hemmer S, Wasenius VM, Knuutila S, Franssila K, Joensuu H. DNA copy number changes in thyroid carcinoma. Am J Surg Pathol 1999, 154:1539-1547.
19. Marsh DJ, Theodosopoulos G, Martin-Schulte K, Richardson AL, Philips J, Röher HD, Delbridge L, Robinson BG. Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 2003, 88:1866-1872. 10.1210/jc.2002-021155, 12679485.
20. Ameur N, Lacroix L, Roucan S, Roux V, Broutin S, Talbot M, Dupuy C, Caillou B, Schlumberger M, Bidart JM. Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways. Endocr Relat Cancer 2009, 16:1261-1272. 10.1677/ERC-08-0289, 19675075.
21. Santarius T, Shipley J, Brewer D, Stratton MR, Cooper CS. A census of amplified and overexpressed human cancer genes. Nat Rev Cancer 2010, 10:59-64. 10.1038/nrc2771, 20029424.
22. Knuutila S, Björkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y. DNA copy number amplification in human neoplasm. Am J Pathol 1998, 152:1107-1123. 1858578, 9588877.